CCEL Q3 2021 Earnings — Cryo-Cell International, Inc. Revenue & Financial Results | Market Cap Arena

CCELCryo-Cell International, Inc.

$26M

Q3 2021 Earnings

Healthcare Medical - Care Facilities

Income Statement

Revenue

$8M-7.5% YoY

Gross Profit

$5M67.2% margin

Operating Income

$2M21.3% margin

Net Income

$856,49411.4% margin

EPS (Diluted)

$0.10

QoQ Revenue Growth

+4.1%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$527,737

Stock-Based Comp.

$81,297

Balance Sheet

Total Assets

$59M

Total Liabilities

$55M

Stockholders' Equity

$5M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$8M	-7.5%
Gross Profit	$5M	$6M	-12.3%
Operating Income	$2M	$2M	-35.6%
Net Income	$856,494	$784,467	+9.2%

Revenue Segments

Processing And Storage Fees

$7M98%

Public Banking

$158,9362%

Product

$18,2000%